Heart News and Research

RSS

Sports and exercise - in addition to preventing obesity and diabetes - directly improve vascular function and reduce atherosclerosis

When asked about his personal recipe for old age, Winston Churchill used to answer: "First of all: No sports." While being a visionary figure in world politics researchers in cardiovascular exercise science today would unanimously reply to his medical hypothesis: "Sorry, you are wrong."

5 Sep 2005

Results of cardiac resynchronization therapy (CRT)

During the last decade, cardiac resynchronization, as adjunctive therapy for patients with severe chronic heart failure has been the subject of many clinical trials.

5 Sep 2005

Advice to cardiac patients regarding sports and exercise

Increased levels of physical activity are known today to be one of the most powerful protective factors against cardiovascular disease and its progression.

5 Sep 2005

Telemonitoring of multiple vital parameters of patients with chronic heart disease is feasible

Chronic heart failure (CHF) is a frequent syndrome with an increasing prevalence. It is a frequent cause of impeding symptoms, has a negative prognosis and absorbs about two percent of the budgets of health-care systems in the industrialized nations.

5 Sep 2005

Chronic heart failure (CHF) is common, deadly, disabling, costly but fortunately - treatable

During the last ten to 15 years, treatment of CHF has been dramatically improved by pharmacological therapy and devices. Treatment also has become more complicated.

5 Sep 2005

Vitamin B may do more harm than good in heart attack patients

Researchers from Norway have found that treating patients who have had a heart attack with high doses of B vitamins does not lower the risk of getting another heart attack or stroke. Contrary to expectations, B vitamins may do more harm than good.

5 Sep 2005

Heart failure patients are "a country" in Europe, there are so many

The number of hospitalizations for heart failure is about the same as for acute myocardial infarction. Our knowledge over acute heart failure patients treated at hospitals for heart failure is based on surveys. In Europe the information is still scarce but emerging especially through the European Society of Cardiology (ESC) Euroheart survey program.

5 Sep 2005

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduced the risk of cardiovascular death, heart attack or stroke within 30 days following the procedure, according to an article in the September 14 issue of JAMA: The Journal of the American Medical Association.

5 Sep 2005

World's largest study on acute coronary syndromes

A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.

5 Sep 2005

New blood pressure-lowering drugs reduce stroke risk by 50%

According to researchers the new types of blood pressure-lowering drugs are more effective in preventing strokes and heart attacks and save even more lives.

5 Sep 2005

Rett Syndrome gene discovery

Adrian Bird of the University of Edinburgh and colleagues report in the online issue of Molecular Cell that the "Rett Syndrome protein", MeCP2, only binds to genes with a specific sequence of nucleotide bases. This knowledge will aid in the identification of the genes that are regulated by the gene MECP2

4 Sep 2005

Medication before angiograph significantly reduces risk of heart attack

According to new research if patients are given the a drug which reduces platelet activity in the blood risk of heart attack and cardiovascular death before and after angioplasty is reduced.

4 Sep 2005

Can a new combination treatment prevent a secondary stroke in children with sickle cell anemia?

St. Jude Children’s Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.

1 Sep 2005

C. elegans worm provides clues to dealing with human disease

A step towards understanding cell mutations that cause a variety of human diseases, particularly in children -- including that which brings about premature aging and early death -- has been taken by researchers at the Hebrew University of Jerusalem Silberman Institute of Life Sciences and the John Hopkins University School of Medicine.

1 Sep 2005